Le Zhen

651 total citations
37 papers, 509 citations indexed

About

Le Zhen is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Le Zhen has authored 37 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 11 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Le Zhen's work include Catalytic C–H Functionalization Methods (8 papers), Sulfur Compounds in Biology (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Le Zhen is often cited by papers focused on Catalytic C–H Functionalization Methods (8 papers), Sulfur Compounds in Biology (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Le Zhen collaborates with scholars based in China, United States and United Kingdom. Le Zhen's co-authors include Guangji Wang, Qing‐Long Xu, Hongbin Sun, Xiaoan Wen, Gregory L. Rorrer, Fanghui Ren, Jeremy Campbell, Jing Yang, Alan X. Wang and Yilin Sun and has published in prestigious journals such as Analytical Chemistry, Journal of Medicinal Chemistry and Carbohydrate Polymers.

In The Last Decade

Le Zhen

36 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Le Zhen China 14 195 167 76 74 55 37 509
Anantha Krishnan Dhanabalan India 14 196 1.0× 133 0.8× 56 0.7× 158 2.1× 18 0.3× 36 482
Baolin Wang China 12 137 0.7× 154 0.9× 38 0.5× 75 1.0× 20 0.4× 30 443
Aarajana Shrestha South Korea 19 334 1.7× 330 2.0× 98 1.3× 95 1.3× 21 0.4× 35 627
William C. Putnam United States 13 114 0.6× 336 2.0× 70 0.9× 64 0.9× 14 0.3× 33 602
Eric A. Tanifum United States 14 90 0.5× 154 0.9× 29 0.4× 44 0.6× 55 1.0× 27 485
Laleh Alisaraie Canada 13 114 0.6× 188 1.1× 43 0.6× 54 0.7× 58 1.1× 27 555
Tim Quach Australia 17 203 1.0× 234 1.4× 71 0.9× 128 1.7× 69 1.3× 29 757
Yusra Rahman India 9 111 0.6× 311 1.9× 28 0.4× 204 2.8× 32 0.6× 11 442
Pritam Thapa United States 8 247 1.3× 143 0.9× 55 0.7× 36 0.5× 16 0.3× 13 471
I-Lin Lu Taiwan 13 93 0.5× 295 1.8× 72 0.9× 69 0.9× 94 1.7× 19 640

Countries citing papers authored by Le Zhen

Since Specialization
Citations

This map shows the geographic impact of Le Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Zhen more than expected).

Fields of papers citing papers by Le Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Zhen. The network helps show where Le Zhen may publish in the future.

Co-authorship network of co-authors of Le Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Le Zhen. A scholar is included among the top collaborators of Le Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Zhen. Le Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mengying, Zhonghong Wei, Bin Wei, et al.. (2025). Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy. Cell Host & Microbe. 33(6). 915–931.e9. 4 indexed citations
2.
Jin, Xin, et al.. (2025). Design, synthesis, and anti-cancer evaluation of NQO1-responsive prodrug of gemcitabine. European Journal of Medicinal Chemistry. 300. 118146–118146.
3.
Zhang, Yu‐Qing, et al.. (2025). Colon-Targeting Supersulfide Donor–Drug Conjugates Align Forces against Inflammation. JACS Au. 5(2). 642–652. 1 indexed citations
4.
Chen, Bin, Cheng Cheng, Yunhao Wu, et al.. (2024). PGC-1α-mediated imbalance of mitochondria-lipid droplet homeostasis in neomycin-induced ototoxicity and nephrotoxicity. Acta Pharmaceutica Sinica B. 14(10). 4413–4430. 13 indexed citations
5.
Ni, Qi, Le Zhen, Zhu Zeng, et al.. (2024). Mesenchymal stromal cells restrain the Th17 cell response via L-amino-acid oxidase within lymph nodes. Cell Death and Disease. 15(9). 640–640. 2 indexed citations
6.
Xie, Tao, et al.. (2024). In pursuit of feedback activation: New insights into redox-responsive hydropersulfide prodrug combating oxidative stress. Redox Biology. 72. 103130–103130. 4 indexed citations
7.
Ma, Jie, Tianyu Hu, Xin Jin, et al.. (2024). Thio-ProTide strategy: A novel H2S donor–drug conjugate (DDC) alleviates hepatic injury via innate lysosomal targeting. Acta Pharmaceutica Sinica B. 14(12). 5341–5356. 1 indexed citations
8.
Chen, Long, Sai Liu, Yuan‐Ting Sun, et al.. (2023). Hydrocortisone Mitigates Alzheimer’s-Related Cognitive Decline through Modulating Oxidative Stress and Neuroinflammation. Cells. 12(19). 2348–2348. 9 indexed citations
9.
Xie, Tao, et al.. (2023). Development and validation for bioanalysis of VK2809, its active metabolite VK2809A and glutathione-conjugated metabolite MB06588 in rat liver using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 234. 115595–115595. 5 indexed citations
10.
Zhao, Yongjie, et al.. (2021). Simultaneous determination of ZL-01, a novel nucleotide prodrug, and its metabolites in rat plasma by LC-MS/MS: Application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 208. 114437–114437. 1 indexed citations
11.
Xie, Tao, et al.. (2021). Cu-Catalyzed Dimerization of Indole Derived Oxime Acetate for Synthesis of Biimidazo[1,2-a]indoles. The Journal of Organic Chemistry. 86(8). 5518–5529. 2 indexed citations
12.
Xu, Cheng, et al.. (2019). Bio-inspired drug-dominated supramolecular nanocomplex based on low molecular weight heparin for progressive tumor therapy. Carbohydrate Polymers. 220. 30–42. 8 indexed citations
13.
Sun, Yilin, Le Zhen, Ying Peng, et al.. (2018). Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2′, 2′-difluorodeoxyuridine in rat plasma by UFLC-MS/MS. Journal of Chromatography B. 1084. 4–13. 7 indexed citations
14.
Yang, Na, Runbin Sun, Xing‐Long Chen, et al.. (2017). In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine. Acta Pharmacologica Sinica. 38(3). 351–361. 36 indexed citations
15.
Zhou, Fang, Le Zhen, Ying Peng, et al.. (2017). Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC–MS/MS method. Journal of Pharmaceutical and Biomedical Analysis. 146. 147–153. 20 indexed citations
16.
Yang, Na, Runbin Sun, Yuqing Zhao, et al.. (2016). High fat diet aggravates the nephrotoxicity of berberrubine by influencing on its pharmacokinetic profile. Environmental Toxicology and Pharmacology. 46. 319–327. 20 indexed citations
18.
Zhang, Yue, Fei Fei, Le Zhen, et al.. (2016). Sensitive analysis and simultaneous assessment of pharmacokinetic properties of crocin and crocetin after oral administration in rats. Journal of Chromatography B. 1044-1045. 1–7. 59 indexed citations
19.
Zhen, Le, et al.. (2014). Intramolecular redox reaction for the synthesis of N-aryl pyrroles catalyzed by Lewis acids. Organic & Biomolecular Chemistry. 12(47). 9716–9719. 19 indexed citations
20.
Xia, Jun, Le Zhen, Xiuling Zhang, et al.. (2011). Synthesis and in vitro evaluation of ambrisentan analogues as potential endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(13). 3894–3897. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026